# Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy

> **NCT01710345** · PHASE2 · COMPLETED · sponsor: **Talphera, Inc** · enrollment: 101 (actual)

## Conditions studied

- Acute Pain

## Interventions

- **DRUG:** Sufentanil NanoTab 20 mcg
- **DRUG:** Sufentanil NanoTab 30 mcg
- **DRUG:** Placebo NanoTab

## Key facts

- **NCT ID:** NCT01710345
- **Lead sponsor:** Talphera, Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2013-02
- **Final completion:** 2013-02
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2015-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01710345

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01710345, "Safety and Efficacy of Sufentanil NanoTab for Management of Acute Pain Following Bunionectomy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01710345. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*